Edition:
United Kingdom

CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

20.80HKD
25 Apr 2018
Change (% chg)

HK$0.45 (+2.21%)
Prev Close
HK$20.35
Open
HK$20.30
Day's High
HK$20.90
Day's Low
HK$19.86
Volume
21,117,064
Avg. Vol
24,878,030
52-wk High
HK$23.45
52-wk Low
HK$10.60

Latest Key Developments (Source: Significant Developments)

CSPC Pharmaceutical Group Says FY Profit Attributable HK$2.77 Bln
Monday, 19 Mar 2018 

March 19 (Reuters) - Cspc Pharmaceutical Group Ltd <1093.HK>::FY REVENUE HK$ ‍15.46​ BILLION VERSUS HK$12.37 BILLION.FY PROFIT ATTRIBUTABLE HK$2.77 BILLION VERSUS HK$2.10 BILLION.‍FINAL DIVIDEND PER SHARE HK15.00 CENTS​.  Full Article

CSPC Pharmaceutical Group Says ‍Cancer Drug Granted Drug Clinical Trial Approval By China FDA
Friday, 16 Mar 2018 

March 16 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::‍CANCER DRUG DEVELOPED BY WUHAN YZY BIOPHARMA​ GRANTED DRUG CLINICAL TRIAL APPROVAL BY CHINA FDA.  Full Article

CSPC Pharmaceutical Group Announces Acquisition Of Stake In Wuhan Yzy Biopharma Co
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - CSPC Pharmaceutical Group <1093.HK>::ACQUISITION OF 39.56% EQUITY INTEREST IN WUHAN YZY BIOPHARMA CO., LTD.DEAL FOR UP TO RMB356 MILLION.  Full Article

CSPC Pharmaceutical Group Says Unit's Listing Application To CSRC Was Accepted
Wednesday, 27 Dec 2017 

Dec 27 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::CSPC XNW SUBMITTED APPLICATION TO CSRC FOR PROPOSED A SHARE LISTING ON CHINEXT OF SZSE & RECEIVED NOTICE OF ACCEPTANCE.‍EXPECTED THAT CSPC XNW WILL REMAIN AS AN INDIRECT SUBSIDIARY OF CO.  Full Article

CSPC Pharmaceutical Group announces change of shareholdings of substantial shareholder
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Cspc Pharmaceutical Group Ltd <1093.HK>:‍Massive Giant Group transferred approximately 6.78% of total issued shares to Common Success International​.  Full Article

CSPC Pharmaceutical Group posts 9-month profit attributable of HK$‍2.04​ bln
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>:9-month profit attributable HK$‍2.04​ billion versus HK$1.57 billion.9-month ‍ total revenue HK$11.21 billion versus HK$9.25 billion.  Full Article

CSPC Pharmaceutical Group ‍to issue 189 mln placing shares at HK$12.44 per share​
Thursday, 12 Oct 2017 

Oct 13 (Reuters) - Cspc Pharmaceutical Group Ltd <1093.HK>-:‍shall issue 189 million placing shares at placing price of hk$12.44 per share​.application will be made to stock exchange for resumption of trading with effect from 9:00 a.m. On 13 oct 2017​.  Full Article

CSPC Pharmaceutical Group's unit buys 1.31 PCT stake in CSPC Innovation Pharmaceutical
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>:Unit announces ‍acquisition of 1.31 percent stake in CSPC Innovation Pharmaceutical Co for RMB 9.4 million.Unit signs agreement with vendor Zhongchengxin​.  Full Article

CSPC Pharmaceutical Group receives U.S.FDA orphan-drug designation for malignant tumour treatment drug
Wednesday, 27 Sep 2017 

Sept 27 (Reuters) - CSPC Pharmaceutical Group Ltd<1093.HK>:Group's Malignant Tumour Treatment Drug "Mitoxantrone Hydrochloride Liposome' was granted orphan-drug designation by the U.S. FDA.Mitoxantrone Hydrochloride Liposome is currently under phase ii clinical trial in China.  Full Article

CSPC Pharmaceutical Group says HY revenue was HK$7.20 bln
Tuesday, 22 Aug 2017 

Aug 22 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::HY total revenue HK$7.20 billion versus HK$6.15 billion.Do not declare payment of an interim dividend for six months ended 30 june 2017.HY profit attributable to shareholders HK$1.31 billion versus HK$1.03 billion.  Full Article

Hong Kong stocks follow Asia, Wall Street lower

* HK->Shanghai Connect daily quota used 8.2 pct, Shanghai->HK daily quota used 5.2 pct